Beachbody vs Honest
BODI and HNST side by side, both in nonstore retailers. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BODI and HNST compare
Honest is the larger company, worth 22 times as much as Beachbody ($538M against $24.7M).
On earnings, Beachbody is cheaper: it trades at 2.2× trailing earnings, against 7.5× for Honest.
Honest grew revenue faster over the last twelve months (−12.8% versus −27.6% for Beachbody).
Honest keeps more of each dollar of sales as profit, with a net margin of 23.5% compared with 5.9% at Beachbody.
Honest scores higher on the StockData Score (12 against 9 for Beachbody), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BODI | HNST |
|---|---|---|
| Size and price | ||
| Market cap | $24.7M | $538M |
| Share price | $3.38 | $5.01 |
| Change, 1 year | −42.5% | 83.0% |
| Change, 5 years | −97.5% | −40.7% |
| Beta (5Y) | 1.05 | 1.70 |
| Employees | 270 | 174 |
| StockData Score | ||
| Total score | 9 | 12 (better) |
| Valuation score | 4 (better) | 2 |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 0 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 2.2× (better) | 7.5× |
| P/S | 0.1× (better) | 1.6× |
| P/B | 0.6× (better) | 2.0× |
| EV/EBITDA | 0.9× | – |
| P/FCF | – | 11.1× |
| FCF yield | −31.9% | 9.0% (better) |
| Fair value | $41.17 | – |
| Margin of safety | 91.8% | – |
| Growth | ||
| Revenue growth (TTM) | −27.6% | −12.8% (better) |
| Revenue growth, 5Y average | −21.9% | 4.3% (better) |
| Net income growth (TTM) | – | 1009% |
| EPS growth (TTM) | – | 1017% |
| Profitability | ||
| Gross margin | 72.4% (better) | 37.6% |
| Operating margin | 7.0% (better) | −4.2% |
| Net margin | 5.9% | 23.5% (better) |
| FCF margin | −3.8% | 14.5% (better) |
| Return on equity | 36.3% (better) | 34.6% |
| Return on invested capital | 54.3% (better) | −8.0% |
| Financial health | ||
| Debt / equity | 0.54 (better) | 0.00 |
| Net debt / EBITDA | −0.21 | – |
| Interest coverage | 3.4× | – |
| Current ratio | 0.79 | 4.26 (better) |
| Altman Z-score | −4.94 | 6.24 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 23.9% | 48.1% |
| Held by insiders | – | 16.2% |
| Insider net buying, 12 months | – | −$3.8M |
| Short interest, % of float | – | 12.6% |
Go deeper
- BODI stock overview
- BODI income statement
- BODI valuation and score
- HNST stock overview
- HNST income statement
- HNST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.